Open the mobile version, with barcode scanning
Class II Ongoing

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Why: Lack of Assurance of Sterility

Company
PAYLESS COMPOUNDERS, LLC
Beaverton, OR, United States
Reported
Apr 22, 2026
Recall started
Mar 6, 2026
Where sold
OR
Amount
91 vials
Full product description
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Lots / codes affected
Lot Number 01-27-2026@14S.5

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.